Darolutamide tablets (Darolutamide) dosage and usage

The usually recommended standard dose of Darolutamide tablets (Darolutamide) is 600mg (i.e. 300 pan>mg tablets2 tablets), taken twice daily, for a total dose of 1200mg per day. This dose is determined on the basis of safety and effectiveness verified in clinical trials. Patients need to continue taking the medication in strict accordance with the doctor's instructions and cannot increase or decrease the dose or stop the medication at will, so as not to affect the therapeutic effect.

It is recommended to take this medicine with food, that is, after meals, which can improve the absorption efficiency of the medicine. Patients should take it once a day in the morning and evening, 600mg each time, and the interval should be as fixed as possible, such as 8 o'clock in the morning and 8 o'clock in the evening. If you miss a dose, you should take it as soon as possible, but if it is close to the time of the next dose, skip the missed dose and never take a double dose at one time.

For patients with moderately impaired liver or renal function, the need to adjust the dosage should be evaluated under the guidance of a doctor; patients with severe liver or renal dysfunction should use it with caution. In addition, there are insufficient studies to show whether darotamide is safe and effective in children or adolescents under 18 years of age, and therefore its use in the pediatric population is not recommended. Elderly patients generally do not need to adjust the dose, but drug tolerance needs to be monitored regularly.

Darotamide is often used in combination with androgen deprivation therapy (ADT), such as injection of luteinizing hormone-releasing hormone (GnRH) analogues, or continuously in patients undergoing castration surgery. Pay attention to drug-drug interactions during use, especially avoid using strong CYP3A4 inducers or inhibitors at the same time, so as not to affect the metabolism and efficacy of darotamide. If the patient is taking other prescription drugs, he should proactively report this to his doctor.

Reference materials:https://www.fda.gov/drugs/